Quant Healthcare Growth Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

Quant Healthcare Growth Direct Plan

NAV
₹15.7786
-2.08%
(20 Dec)
AUM
440 Cr
TER
0.69%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+36.0%
+34.0%
+33.2%
+32.7%
+20.7%
3Y
NA
+36.3%
+35.8%
+37.7%
+35.8%
5Y
NA
+29.7%
+31.7%
+26.2%
NA
ALL
+37.6%
+17.8%
+18.1%
+12.5%
+28.6%
VOL
16.5%
19.6%
18.1%
20.3%
22.7%
TER
0.7%
0.8%
1.2%
0.7%
0.5%
AUM
₹440 Cr
₹1,345 Cr
₹6,779 Cr
₹4,686 Cr
₹5,456 Cr
INFO
2.27
0.91
1.00
0.62
1.26
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Quant Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Oct
Top holdings
RPG Life Sciences Ltd
8.8%
Aster DM Healthcare Ltd Ordinary Shares
7.2%
Reliance Industries Ltd
7.0%
Aurobindo Pharma Ltd
6.9%
Pfizer Ltd
6.7%
HFCL Ltd
6.6%
GlaxoSmithKline Pharmaceuticals Ltd
6.3%
Ipca Laboratories Ltd
6.2%
Glenmark Life Sciences Ltd
6.0%
Zydus Wellness Ltd
5.7%
Top industry exposure
Healthcare
75.9%
Energy
7.0%
Technology
6.6%
Consumer Defensive
5.7%
Basic Materials
0.6%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 15 days
Fund objective
The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund manager(s)
Sanjeev Sharma
Vasav Sahgal
Ankit A. Pande
Sandeep Tandon

FAQs